For Immediate Release
Chicago, IL – May 14, 2026 – Zacks Investment Research has released its latest featured stocks in the Analyst Blog, highlighting Meta Platforms, Inc. (META), Pfizer Inc. (PFE), Salesforce, Inc. (CRM), and Smith-Midland Corp. (SMID). Today’s reports cover 16 major companies, selected from around 70 total reports published by the analyst team.
In the past year, shares of Meta declined by 7.9%, while Pfizer gained 25.9%, and Salesforce underperformed with a 41.7% drop. Notably, Smith-Midland, a micro-cap firm with a market capitalization of $163.23 million, reported a significant 88% year-over-year increase in nine-month rental revenues. Key numbers from each company underline their unique market positions and growth challenges: Meta is investing heavily in AI, Pfizer is recovering from a sales dip post-COVID, Salesforce faces stiff competition, and Smith-Midland’s backlog supports visibility into 2026 growth.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
